Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Long-term outcomes in patients with duodenal adenocarcinoma.

Lee SY, Lee JH, Hwang DW, Kim SC, Park KM, Lee YJ.

ANZ J Surg. 2014 Dec;84(12):970-5. doi: 10.1111/ans.12112. Epub 2013 May 8.

PMID:
23656271
2.

What prognostic factors are important in duodenal adenocarcinoma?

Bakaeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM, Farley DR, van Heerden JA, Wiersema LM, Schleck CD, Donohue JH.

Arch Surg. 2000 Jun;135(6):635-41; discussion 641-2.

PMID:
10843358
3.

Extent of resection in the management of duodenal adenocarcinoma.

Kaklamanos IG, Bathe OF, Franceschi D, Camarda C, Levi J, Livingstone AS.

Am J Surg. 2000 Jan;179(1):37-41.

PMID:
10737576
4.

Surgical procedure depending on the depth of tumor invasion in duodenal cancer.

Kato Y, Takahashi S, Kinoshita T, Shibasaki H, Gotohda N, Konishi M.

Jpn J Clin Oncol. 2014 Mar;44(3):224-31. doi: 10.1093/jjco/hyt213. Epub 2014 Jan 26.

PMID:
24470586
5.

Clinicopathological analysis and survival outcome of duodenal adenocarcinoma.

Kim MJ, Choi SB, Han HJ, Park PJ, Kim WB, Song TJ, Suh SO, Choi SY.

Kaohsiung J Med Sci. 2014 May;30(5):254-9. doi: 10.1016/j.kjms.2013.12.006. Epub 2014 Jan 17.

6.

Long-term results of radical resection for locally advanced duodenal adenocarcinoma.

Bucher P, Gervaz P, Morel P.

Hepatogastroenterology. 2005 Nov-Dec;52(66):1727-9.

PMID:
16334766
7.

Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China.

Jiang QL, Huang XH, Chen YT, Zhang JW, Wang CF.

Biomed Res Int. 2016;2016:6491049. doi: 10.1155/2016/6491049. Epub 2016 Dec 27.

8.

Primary duodenal adenocarcinoma: a ten-year experience with 79 patients.

Rose DM, Hochwald SN, Klimstra DS, Brennan MF.

J Am Coll Surg. 1996 Aug;183(2):89-96.

PMID:
8696551
9.

Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment.

Poultsides GA, Huang LC, Cameron JL, Tuli R, Lan L, Hruban RH, Pawlik TM, Herman JM, Edil BH, Ahuja N, Choti MA, Wolfgang CL, Schulick RD.

Ann Surg Oncol. 2012 Jun;19(6):1928-35. doi: 10.1245/s10434-011-2168-3. Epub 2011 Dec 14.

10.

Survival predictors of patients with primary duodenal adenocarcinoma.

Kawahira H, Miura F, Saigo K, Matsunaga A, Natsume T, Akai T, Horibe D, Suzuki K, Nabeya Y, Hayashi H, Miyauchi H, Shuto K, Asano T, Matsubara H.

Int Surg. 2011 Apr-Jun;96(2):111-6.

PMID:
22026300
11.

Primary duodenal adenocarcinoma: a 40-year experience.

Ryder NM, Ko CY, Hines OJ, Gloor B, Reber HA.

Arch Surg. 2000 Sep;135(9):1070-4; discussion 1074-5.

PMID:
10982512
12.

Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.

Tran TB, Qadan M, Dua MM, Norton JA, Poultsides GA, Visser BC.

Surgery. 2015 Aug;158(2):486-93. doi: 10.1016/j.surg.2015.03.048. Epub 2015 May 23.

PMID:
26013988
13.

Number of involved lymph nodes is important in the prediction of prognosis for primary duodenal adenocarcinoma.

Liang TJ, Wang BW, Liu SI, Chou NH, Tsai CC, Chen IS, Yeh MH, Chen YC, Chang PM, Mok KT.

J Chin Med Assoc. 2012 Nov;75(11):573-80. doi: 10.1016/j.jcma.2012.08.002. Epub 2012 Oct 10.

14.

Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.

Zenali M, Overman MJ, Rashid A, Broaddus RB, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H.

Hum Pathol. 2013 Dec;44(12):2792-8. doi: 10.1016/j.humpath.2013.07.030. Epub 2013 Oct 15.

15.

Prognostic value of the TNM-classification for small bowel cancer.

Contant CM, Damhuis RA, van Geel AN, van Eijck CH, Wiggers T.

Hepatogastroenterology. 1997 Mar-Apr;44(14):430-4.

PMID:
9164514
16.

Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer.

Sarela AI, Brennan MF, Karpeh MS, Klimstra D, Conlon KC.

Ann Surg Oncol. 2004 Apr;11(4):380-6. Epub 2004 Mar 15.

PMID:
15070597
17.

Primary adenocarcinoma of third and fourth portions of duodenum. Favorable prognosis after resection.

Lowell JA, Rossi RL, Munson JL, Braasch JW.

Arch Surg. 1992 May;127(5):557-60.

PMID:
1349472
18.

Pancreaticoduodenectomy versus local resection in the treatment of gastrointestinal stromal tumors of the duodenum.

Zhou B, Zhang M, Wu J, Yan S, Zhou J, Zheng S.

World J Surg Oncol. 2013 Aug 14;11:196. doi: 10.1186/1477-7819-11-196.

19.

Outcome after surgical resection for duodenal adenocarcinoma in the UK.

Solaini L, Jamieson NB, Metcalfe M, Abu Hilal M, Soonawalla Z, Davidson BR, McKay C, Kocher HM; UK Duodenal Cancer Study Group.

Br J Surg. 2015 May;102(6):676-81. doi: 10.1002/bjs.9791. Epub 2015 Mar 16.

PMID:
25776995
20.

Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma.

Malleo G, Tonsi A, Marchegiani G, Casarotto A, Paiella S, Butturini G, Salvia R, Bassi C.

Langenbecks Arch Surg. 2013 Feb;398(2):287-94. doi: 10.1007/s00423-012-0978-9. Epub 2012 Jul 17.

PMID:
22801737

Supplemental Content

Support Center